Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 2

University of Manitoba

Status: Completed

Conditions: Obesity Prevention; Diabetes Prevention

Treatments: Dietary Supplement: Soybean Shake; Dietary Supplement: Soybean; Dietary Supplement: Hemp Shake; Dietary Supplement: Hemp; Dietary Supplement: Control

Study type: Interventional

Funder types: Other

Identifiers

NCT02458027

B2014:115-3

Details and patient eligibility

About

The objectives of this trial are to investigate whether the effects of hemp protein on glycemic and appetite control are insulin-dependent by measuring 1) blood glucose, insulin and appetite for one hour following consumption, 2) blood glucose, insulin and appetite following a fixed energy meal to determine the "second meal effect" of hemp protein versus soybean protein and a non-protein control.

Full description

The objectives of this trial are to investigate whether the effects of hemp protein on glycemic and appetite control are insulin-dependent by measuring 1) blood glucose, insulin and appetite for one hour following consumption, 2) blood glucose, insulin and appetite following a fixed energy meal to determine the "second meal effect" of hemp protein versus soybean protein and a non-protein control. The objectives of this trial are to investigate whether the effects of hemp protein on glycemic and appetite control are insulin-dependent by measuring 1) blood glucose, insulin and appetite for one hour following consumption, 2) blood glucose, insulin and appetite following a fixed energy meal to determine the "second meal effect" of hemp protein versus soybean protein and a non-protein control.

Enrollment: 15 patients

Sex: All

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Normoglycemic (<5.6 mmol/L)
• Body mass index (BMI) of 18.5-29.9 kg/m2.

Exclusion criteria

• Restrained eaters
• Regularly skip breakfast
• Smokers
• Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

15 participants in 5 patient groups, including a placebo group

20g Hemp Protein Shake

Experimental group

Description:

Hemp protein shake, 20 grams, given once at beginning of acute trial.

Treatment:

Dietary Supplement: Hemp Shake

40 g Hemp Protein

Experimental group

Description:

Hemp protein shake, 40 grams, given once, at beginning of acute trial.

Treatment:

Dietary Supplement: Hemp

20 g Soybean Protein Shake

Active Comparator group

Description:

Soybean protein shake, 20 grams, given once, at beginning of acute trial.

Treatment:

Dietary Supplement: Soybean Shake

40 g Soybean Protein

Experimental group

Description:

Soybean protein shake, 40 grams, given once, at beginning of acute trial.

Treatment:

Dietary Supplement: Soybean

Control Shake

Placebo Comparator group

Description:

Non-protein control shake, given once, at beginning of acute trial.

Treatment:

Dietary Supplement: Control